← Back to Search

Opioid

methadone group for Long QT Syndrome

Phase 4
Recruiting
Led By Glenn S Murphy, MD
Research Sponsored by NorthShore University HealthSystem
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All patients presenting for elective surgical cases requiring general anesthesia and associated with moderate-to-severe postoperative pain will be eligible for enrollment.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes after post anesthesia care unit admission
Awards & highlights

Study Summary

This study is evaluating whether a drug called methadone may help reduce the risk of a potentially lethal heart rhythm problem in patients who have undergone surgery.

Eligible Conditions
  • Long QT Syndrome

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes after postanesthesia care unit admission
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes after postanesthesia care unit admission for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
QT prolongation on the EKG 30 minutes after postanesthesia care unit admission
Secondary outcome measures
Level of pain on a 0-10 scale on the morning of postoperative day one
Level of pain on on a 0-10 scale 30 minutes after postanesthesia care unit admission
QT prolongation on the EKG on the morning of postoperative day one

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: methadone groupActive Control1 Intervention
Patients in this group will receive a syringe of methadone at the induction of anesthesia and a syringe of saline at the end of anesthesia.
Group II: hydromorphone groupPlacebo Group1 Intervention
Patients in this group will receive a syringe of saline at induction of anesthesia and a syringe of hydromorphone at the end of anesthesia

Find a Location

Who is running the clinical trial?

NorthShore University HealthSystemLead Sponsor
132 Previous Clinical Trials
737,720 Total Patients Enrolled
Glenn S Murphy, MDPrincipal InvestigatorNorthShore University HealthSystem
8 Previous Clinical Trials
1,010 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~20 spots leftby Apr 2025